分子病变,器官转移,以及针对非小细胞肺癌的向治疗
Salik Abdullah1, Ratul Chakraborty2, Pratiksha Somnath Kumkar3
1Department of Pharmaceutical Chemistry, Bharat Technology under Maulana Abul Kalam Azad University of Technology, West Bengal, Banitabla, Uluberia, Howrah-711316, West Bengal, India.
概括
针对非小细胞肺癌 (NSCLC) 的个性化药物正在进步,这是由于基因发现. 基于分子分析的向疗法正在改善患者的生存率和治疗策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 肺癌影响全球数百万人,非小细胞肺癌 (NSCLC) 是最常见的类型.
- 近几十年来,人们在了解肺癌的遗传情景方面取得了重大进展.
- 这导致了治疗高级或转移性NSCLC的范式转变.
研究的目的:
- 审查非小细胞肺癌的分子遗传景观.
- 讨论NSCLC治疗的最新进展.
- 突出诊断和治疗中的临床相关变化.
主要方法:
- 在NSCLC中进行分子遗传分析的审查.
- 分析针对性治疗的进展情况.
- 检查诊断测试方法和标准化.
主要成果:
- 在NSCLC中发现持久的遗传异常.
- 开发提高中位生存时间的向药物.
- 基于遗传特征和预后指标的个性化治疗策略.
结论:
- 分子遗传分析已经彻底改变了NSCLC患者的护理.
- 针对性疗法为高级NSCLC提供了更好的结果.
- 标准化诊断测试对于有效的个性化治疗至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


